Vaccine characteristics and acceptability of HIV immunization among adolescents

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

HIV immunization programmes will only be effective if sufficient numbers of persons accept the vaccine. Our aims were to evaluate HIV vaccine acceptability among adolescents and to examine how vaccine characteristics influence acceptability. We recruited 661 adolescents from community health clinics in Indianapolis, Indiana, USA to complete either written or computerized questionnaires, both of which assessed HIV vaccine acceptability as a function of efficacy, cost, type of vaccine, mode of delivery, and parental permission for immunization (required or not required). For both the written and computer methods, efficacy had the strongest effect on acceptability, followed by type of vaccine and cost. Low efficacy, high cost, and live-attenuated vaccines were associated with lower acceptability. These findings suggest that as efforts to develop HIV vaccines continue, it will be important, in parallel, to anticipate potential obstacles to vaccine acceptance, including the belief that a less efficacious HIV vaccine is unacceptable.

Original languageEnglish
Pages (from-to)143-149
Number of pages7
JournalInternational Journal of STD and AIDS
Volume11
Issue number3
DOIs
StatePublished - 2000

Fingerprint

AIDS Vaccines
Immunization
Vaccines
HIV
Costs and Cost Analysis
Immunization Programs
Attenuated Vaccines

Keywords

  • Adolescence
  • AIDS vaccines
  • Attitude
  • Patient acceptance of health care

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Immunology

Cite this

Vaccine characteristics and acceptability of HIV immunization among adolescents. / Zimet, G. D.; Blythe, M. J.; Fortenberry, J. D.

In: International Journal of STD and AIDS, Vol. 11, No. 3, 2000, p. 143-149.

Research output: Contribution to journalArticle

@article{2a1007de79314a9fbe588caf1c1a5fe9,
title = "Vaccine characteristics and acceptability of HIV immunization among adolescents",
abstract = "HIV immunization programmes will only be effective if sufficient numbers of persons accept the vaccine. Our aims were to evaluate HIV vaccine acceptability among adolescents and to examine how vaccine characteristics influence acceptability. We recruited 661 adolescents from community health clinics in Indianapolis, Indiana, USA to complete either written or computerized questionnaires, both of which assessed HIV vaccine acceptability as a function of efficacy, cost, type of vaccine, mode of delivery, and parental permission for immunization (required or not required). For both the written and computer methods, efficacy had the strongest effect on acceptability, followed by type of vaccine and cost. Low efficacy, high cost, and live-attenuated vaccines were associated with lower acceptability. These findings suggest that as efforts to develop HIV vaccines continue, it will be important, in parallel, to anticipate potential obstacles to vaccine acceptance, including the belief that a less efficacious HIV vaccine is unacceptable.",
keywords = "Adolescence, AIDS vaccines, Attitude, Patient acceptance of health care",
author = "Zimet, {G. D.} and Blythe, {M. J.} and Fortenberry, {J. D.}",
year = "2000",
doi = "10.1258/0956462001915570",
language = "English",
volume = "11",
pages = "143--149",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Vaccine characteristics and acceptability of HIV immunization among adolescents

AU - Zimet, G. D.

AU - Blythe, M. J.

AU - Fortenberry, J. D.

PY - 2000

Y1 - 2000

N2 - HIV immunization programmes will only be effective if sufficient numbers of persons accept the vaccine. Our aims were to evaluate HIV vaccine acceptability among adolescents and to examine how vaccine characteristics influence acceptability. We recruited 661 adolescents from community health clinics in Indianapolis, Indiana, USA to complete either written or computerized questionnaires, both of which assessed HIV vaccine acceptability as a function of efficacy, cost, type of vaccine, mode of delivery, and parental permission for immunization (required or not required). For both the written and computer methods, efficacy had the strongest effect on acceptability, followed by type of vaccine and cost. Low efficacy, high cost, and live-attenuated vaccines were associated with lower acceptability. These findings suggest that as efforts to develop HIV vaccines continue, it will be important, in parallel, to anticipate potential obstacles to vaccine acceptance, including the belief that a less efficacious HIV vaccine is unacceptable.

AB - HIV immunization programmes will only be effective if sufficient numbers of persons accept the vaccine. Our aims were to evaluate HIV vaccine acceptability among adolescents and to examine how vaccine characteristics influence acceptability. We recruited 661 adolescents from community health clinics in Indianapolis, Indiana, USA to complete either written or computerized questionnaires, both of which assessed HIV vaccine acceptability as a function of efficacy, cost, type of vaccine, mode of delivery, and parental permission for immunization (required or not required). For both the written and computer methods, efficacy had the strongest effect on acceptability, followed by type of vaccine and cost. Low efficacy, high cost, and live-attenuated vaccines were associated with lower acceptability. These findings suggest that as efforts to develop HIV vaccines continue, it will be important, in parallel, to anticipate potential obstacles to vaccine acceptance, including the belief that a less efficacious HIV vaccine is unacceptable.

KW - Adolescence

KW - AIDS vaccines

KW - Attitude

KW - Patient acceptance of health care

UR - http://www.scopus.com/inward/record.url?scp=0034009766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034009766&partnerID=8YFLogxK

U2 - 10.1258/0956462001915570

DO - 10.1258/0956462001915570

M3 - Article

C2 - 10726935

AN - SCOPUS:0034009766

VL - 11

SP - 143

EP - 149

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 3

ER -